IJR News — today's news from every side

IJR News — today's news from every side

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

Argenx plans $2.2B Forte Biosciences deal — Jul 27, 2026Argenx has agreed to acquire Forte Biosciences for about $2.2 billion in cash, offering $77 per Forte share and funded entirely from Argenx’s cash to complete a Q3 2026 closing after standard approvals and tender conditions. The deal adds Forte’s FB102, a first-in-class CD122 antibody for vitiligo and celiac disease with potential broader autoimmune applications, boosting Argenx's immunology pipeline beyond Vyvgart.